Weekly Recap | Upstream Bio -0.72%, most brokers rate it buyWeekly Review·Oct 24, 2026 at 07:12 AMUPB-8.36%
Weekly Recap | Sellas Life Sciences +15.63%, consensus target well above spotWeekly Review·Oct 24, 2026 at 07:01 AMSLS+1.67%
Weekly Recap | Summit Therapeutics +5.74%, ivonescimab data stack upWeekly Review·Oct 24, 2026 at 07:00 AMSMMT-0.51%
Weekly Recap | Beigene +2.32%, Tevimbra combination survival data landsWeekly Review·Oct 24, 2026 at 06:49 AMONC-1.21%
Weekly Recap | Moderna -8.22%, sell-off after cancer vaccine dataWeekly Review·Oct 24, 2026 at 06:41 AMMRNA-1.25%MRNY-2.25%
Weekly Recap | Jasper Therapeutics +6.27%, consensus target above spotWeekly Review·Oct 24, 2026 at 06:41 AMJSPR+2.91%
Weekly Recap | Legend Biotech +4.27%, consensus target above spotWeekly Review·Oct 24, 2026 at 06:36 AMLEGN+1.96%
Weekly Recap | IOVA.US +3.45%, outperforming the S&P 500Weekly Review·Oct 24, 2026 at 06:31 AMIOVA-0.35%
Weekly Recap | Cybin -3.41%, consensus target above spotWeekly Review·Oct 24, 2026 at 06:23 AMHELP-2.95%
Weekly Recap | Adma Biologics +3.62%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 06:17 AMADMA-2.47%
Weekly Recap | Adma Biologics -4.05%, rally fades into pullbackWeekly Review·Sep 12, 2026 at 07:41 AMADMA-2.47%
The Nasdaq Biotechnology Index rose over 2.6%, outperforming the broader US stock market. Among constituents, Sarepta Therapeutics surged 34.98%, Summit Therapeutics Plc. rose 15.53%, Enliven Therapeutics increased 14.06%, Upstream Bio gained 12.07%, Taysha Gene climbed 10.90%, Gossamer Bio advanced 10.61%, and Oruka Therapeutics was up 9.80%. Conversely, Aardvark Therapeutics fell 6.10%, ADMA Biologics dropped 15.23%, Anavex Life Sciences declined 34.61%, and Maze Therapeutics fell 35.24%Wallstreetcn·Mar 25, 2026 at 08:50 PMXBI-1.38%TSHA-1.12%
The Nasdaq Biotechnology Index rose by 1.29%. Among the constituent stocks, CG Oncology increased by 24.99%, UroGen Pharma rose by 14.08%, and ADMA Biologics climbed by 12.03%. In contrast, Neurogene fell by 5.91%, Amylyx Pharmaceuticals dropped by 6.53%, and Q32 Bio decreased by 9.89%Wallstreetcn·Apr 28, 2025 at 08:42 PMCGON-1.33%ADMA-2.47%
